| Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021 | 93 | 2021 |
| R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis NN Shah, A Szabo, SF Huntington, N Epperla, N Reddy, S Ganguly, ... British journal of haematology 180 (4), 534-544, 2018 | 91 | 2018 |
| Diffuse large B‐cell lymphoma with primary treatment failure: ultra‐high risk features and benchmarking for experimental therapies LJ Costa, K Maddocks, N Epperla, NM Reddy, R Karmali, E Umyarova, ... American journal of hematology 92 (2), 161-170, 2017 | 84 | 2017 |
| Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy N Epperla, A Li, B Logan, C Fretham, S Chhabra, M Aljurf, L Chee, ... British journal of haematology 189 (6), 1171-1181, 2020 | 78 | 2020 |
| Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study N Epperla, M Hamadani, AF Cashen, KW Ahn, E Oak, AS Kanate, ... Hematological oncology 35 (4), 528-535, 2017 | 70 | 2017 |
| Burkitt lymphoma international prognostic index AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ... Journal of clinical oncology 39 (10), 1129-1138, 2021 | 64 | 2021 |
| Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis G Dang, N Epperla, V Muppidi, N Sahr, A Pan, P Simpson, LB Kreuziger Asaio Journal 63 (4), 373-385, 2017 | 63 | 2017 |
| Incidence and survival trends in mantle cell lymphoma. N Epperla, M Hamadani, TS Fenske, LJ Costa British Journal of Haematology 181 (5), 2018 | 60 | 2018 |
| Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ... JAMA oncology 7 (7), 993-1003, 2021 | 53 | 2021 |
| Emerging therapies in mantle cell lymphoma W Hanel, N Epperla Journal of hematology & oncology 13, 1-18, 2020 | 53 | 2020 |
| Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy IB Greenwell, AD Staton, MJ Lee, JM Switchenko, DF Saxe, JJ Maly, ... Cancer 124 (11), 2306-2315, 2018 | 52 | 2018 |
| Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia N Epperla, W Hocking Clinical Medicine & Research 13 (1), 32-35, 2015 | 44 | 2015 |
| Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant N Ghosh, S Ahmed, KW Ahn, M Khanal, C Litovich, M Aljurf, VU Bacher, ... JAMA oncology 6 (7), 1011-1018, 2020 | 43 | 2020 |
| Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: current controversies and advances N Epperla, M Hamadani Hematology/oncology and stem cell therapy 10 (4), 277-284, 2017 | 41 | 2017 |
| Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone N Epperla, F McKiernan Springerplus 4, 1-7, 2015 | 40 | 2015 |
| Sjögren’s syndrome and neuromyelitis optica spectrum disorders (NMOSD)-a case report and review of literature A Jayarangaiah, R Sehgal, N Epperla BMC neurology 14, 1-6, 2014 | 39 | 2014 |
| Phase I trial of N-803, an IL15 receptor agonist, with rituximab in patients with indolent non-Hodgkin lymphoma JA Foltz, BT Hess, V Bachanova, NL Bartlett, MM Berrien-Elliott, ... Clinical Cancer Research 27 (12), 3339-3350, 2021 | 38 | 2021 |
| HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, AV Danilov, M Bower, ... Blood advances 5 (14), 2852-2862, 2021 | 37 | 2021 |
| Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma … N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ... Journal of Hematology & Oncology 12, 1-11, 2019 | 35 | 2019 |
| Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib NM Denlinger, N Epperla, BM William Cancer Management and Research, 615-624, 2018 | 35 | 2018 |
